NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Jun 03 2026

· Issued by NATCO Pharma Limited via NSE India

Filed with NSE · · 2 pages · English

On 6ix: 6ix.com/news/press-release-jun-03-2026-19

Release

Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "NATCO Pharma Limited and Lupin Limited receive approval from U.S. FDA for Eribulin Mesylate Injection".

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

Later from NATCO Pharma

All NATCO Pharma news releases